Corteva (CTVA) Bets On A Belgian Partner For Crop Protection’s Next Act

On September 9, Corteva (NYSE: CTVA ) and Belgium's Globachem N.V. announced a definitive agreement to form a 50/50 joint venture aimed at developing and commercializing new crop protection products for farmers in Europe and the Americas. The timing matters. Corteva's crop protection business is set to spin off as a standalone public company, Vylor, on October 1, and this deal signals what that company intends to look like once it is on its own.

The joint venture builds on an existing multi-year relationship between the two companies, so this is not a cold start. Corteva brings late-pipeline and commercial-stage technology along with its own discovery and development capabilities, while Globachem contributes expertise in formulation and regulatory execution built as a private Belgian crop protection marketer. Corteva frames the venture as a way to combine those strengths and speed up delivery of more tailored crop protection solutions for core markets. The JV will operate independently, and any resulting products can be commercialized by either parent company, or both.

The deal arrives against a backdrop of real financial momentum. In the first half of 2026, Corteva's net sales rose 4% to $11.28 billion, and operating EBITDA climbed 10% to $3.70 billion. Crop Protection itself posted a 2% volume increase in the first half, which the company attributed to demand for new products, and segment operating EBITDA rose 9% to $776 million even as pricing worked against it. That combination of rising volumes and expanding margins is the kind of foundation a soon-to-be standalone crop protection company would want heading into a major structural change.

Not every number told the same story. Corteva's second-quarter results, taken alone, were softer: net sales fell 1% year over year to $6.38 billion, organic sales declined 2%, and income from continuing operations dropped 12% to $1.22 billion, pulling GAAP earnings per share down 10% to $1.81. Operating EBITDA still grew in the quarter, but the gap between GAAP and non-GAAP performance is a reminder that reported profitability did not move in the same direction as the adjusted metrics investors tend to focus on.

Pricing remains the sharper problem inside Crop Protection specifically. The segment's price declined 3% in the first half and 4% in the second quarter alone, both tied to competitive dynamics in Latin America, even as currency and volume gains offset some of the damage. The new joint venture does not fix that anytime soon. Corteva said the JV's new solutions are not expected to launch until the early 2030s, and the transaction itself still needs regulatory clearance before it can close, which the companies target for the fourth quarter of 2026. Meanwhile, Corteva is absorbing the costs and complexity of its own separation, including a $25 million headwind from separation-related timing already built into its full-year guidance.